All Type of News
Yuyu to boost vitamin C brand through e-gaming
E-gaming, also known as e-sports, is relatively unknown to the general public but is followed zealously by gamers and tech savvy people.
Yuyu Pharmaceutical has recently decided to sponsor Star Tale, one of Korea’s...
Pharmacists clash over license for OTC products
The conflict between pharmacists of Oriental and Western medicine is surfacing over who should have the right to sell over-the-counter (OTC) products, considered a lucrative business.
The Ministry of Health and Wel...
Drugmakers’ worst performance will likely rekindling of kickbacks
The country’s pharmaceutical companies including top-tier ones have struggled to find their feet during the first half, even after a government-mandated price cut came into effect last year.
They are still feeling ...
HanAll Biopharma release more affordable drug for pulmonary hypertension
HanAll Biopharma said Tuesday that it will soon launch a more affordable locally-produced sildenafil product ‘Pahdenafil 20 mg tablets’ for the treatment of pulmonary hypertension.
The retail price is set at 1,000 ...
Dong-A Pharmaceutical to market new reflux esophagitis drugDong-A Pharmaceutical announced Tuesday that it has started distributing over-the-counter drug Acinon solution through pharmacies.
The new product, which contains sodium algi...
|
DreamPharma wins approval for world-first incrementally modified drug
A local pharmaceutical company has won approval to produce the world’s first incrementally modified drug (IMD), paving the way for it to enter a new market with lucrative potential.
DreamPharma, an affiliated comp...
Therapeutic potential of GV1001 analyzed in international scientific journal
A flurry of articles were published on GV1001, a pancreatic cancer treatment developed Korea-based developer KAEL-GemVax.
Recently, the results of CPP (cell-penetrating peptide) related study on GV1001 was publishe...
JW Holdings forges strategic tie-up with Japanese pharmaceutical firm
JW Holdings said Monday that it has forged a strategic alliance with a leading Japanese drug firm in an effort to strengthen its global competitiveness.
Under the contract with Sanwa Kagaku Kenkyusho, an affiliated...
Hanmi’s HM95573 designated as ‘Orphan Drug’
Hanmi Pharmaceutical said Tuesday that HM95573, a novel melanoma drug candidate it is currently developing, was designated as an “Orphan Drug” by the Ministry of Health and Welfare. It will receive 600 million won in ...
Sandoz Korea strengthens global prescription drug marketing
Sandoz Korea said Monday it has adopted its marketing communication theme of prescription drugs as ‘Global Extended Portfolio (Global EP)’ in a move to let doctors have a wider scope of options in prescribing Sandoz p...
